Skip to main content

Alogliptin

NDC 45802-150 · Padagis Israel Pharmaceuticals Ltd

Generic nameAlogliptin
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)ALOGLIPTIN BENZOATE
Strength25 mg/1
Pharmacologic classDipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]
Marketing categoryNDA AUTHORIZED GENERIC

Packages

45802-150-65 — 30 TABLET, FILM COATED in 1 BOTTLE (45802-150-65)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

45802-087 — Alogliptin, 45802-103 — Alogliptin, 45802-169 — alogliptin and metformin hydrochloride, 45802-211 — alogliptin and metformin hydrochloride, 45802-260 — Alogliptin Benzoate and Pioglitazone hydrochloride, 45802-351 — Alogliptin Benzoate and Pioglitazone hydrochloride, 45802-402 — Alogliptin Benzoate and Pioglitazone hydrochloride, 45802-499 — Alogliptin Benzoate and Pioglitazone hydrochloride, 50090-5574 — Alogliptin, 50090-5993 — alogliptin and metformin hydrochloride, 63629-4946 — Alogliptin, 64764-123 — alogliptin and pioglitazone, 64764-125 — alogliptin, 64764-250 — alogliptin, 64764-251 — alogliptin and pioglitazone, 64764-253 — alogliptin and pioglitazone, 64764-254 — alogliptin and pioglitazone, 64764-335 — alogliptin and metformin hydrochloride, 64764-337 — alogliptin and metformin hydrochloride, 64764-625 — alogliptin, +2 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels